1281 results about "Pharmaceutical industry" patented technology

<heading lvl="0">Abstract of Disclosure< / heading> An integrated suite of services for consumers, service providers and manufacturers in the pharmaceutical industry is disclosed. The present invention utilizes one or more of the NCPDP standard formats and adopts the switch for an integrated system of, for example, instant adjudication of prescriptions, consumer data warehousing and / or incentive rewards for the consumer. A participating consumer with one card, can instantly purchase pharmaceuticals and charge the transaction to a credit card and earn and apply savings dollars redeemable for pharmaceutical purchases. For a participating service provider, instant adjudication and instant validation of consumer eligibility can be performed. Moreover, a service provider may receive messages related to the patient's medications. Significantly, data is recorded for consumers even when consumers make the pharmaceutical purchase with cash. The system includes a unique card issued to participating consumers. The card is adapted to encode conventional credit or debit card information specific to the participating consumer so that the consumer can consummate a transaction for the purchase of pharmaceuticals without possession of an additional credit card. The system further includes a host processor coupled to the point of sale at the service provider through a leased line or public switch network or the like. When a customer performs a pharmaceutical transaction at the point of sale of the service provider, the host processor coordinates any benefits and data with other prescription benefit management systems through messages transmitted and received from any primary or secondary carrier systems. The host processor further is adapted to facilitate real-time adjudication of claims and checks for any dangerous drug-to-drug interactions. The host processor additionally facilitates any financial processing including the accumulation and redemption of any bonus dollars earned by the consumer. Furthermore, since the card used by the consumer can be encoded with credit or debit card information, the host processor determines the desired payment method and performs the actual financial transaction. Even if the transaction at the point of sale is a cash purchase, the consumer may desire to use his unique card for the accrual of bonus dollars. Therefore, data concerning the transaction (i.e., pharmacy number, prescription number, etc.) can be recorded even for transactions conducted with cash.

The present invention relates to an automatic electrode position apparatus for connecting an electrode to a cell. The invention further provides methods for utilizing the apparatus of the invention. Apparatus and methods are described for studying electrical activities in cell membranes. These methods are especially useful in large scale screening programs in the pharmaceutical industry.

A system and method for managing the development and manufacturing process of a pharmaceutical is disclosed. The method comprises capturing and recording the development and manufacturing history of the pharmaceutical drug in order to generate a product history. The product history is stored on a computer and is searchable in multiple data dimensions in order to easily retrieve information. The system automatically provides compliance management procedures in order to comply with regulatory standards for the pharmaceutical industry.

The invnetion provides a preparation method for a graphene oxide / polyvinylidene fluoride composite ultrafiltration membrane and relates to the preparation method of the graphene oxide / polyvinylidene fluoride composite ultrafiltration membrane. The invention aims to solve the problem of poor hydrophilicity and stain resistance of the existing polyvinylidene fluoride ultrafiltration membrane. The method provided by the invention comprises the following steps of: 1. respectively adding graphene oxide, polyvinylpyrrolidone and polyvinylidene fluoride with N-methylpyrrolidone as solvent, heating and stirring to obtain casting membrane solution; 2. putting the casting membrane solution on a clean glass plate and scrapping to a certain thickness by a coating device, and then immersing distilled water, shedding and drying to obtain the graphene oxide / polyvinylidene fluoride composite ultrafiltration membrane. The preparation method provided by the invention can be applied to the fields of drinking water preparation, food industry, pharmaceutical industry, biotechnology, chemical process and environmental engineering.

The invention discloses a production monitoring system for a traditional Chinese medicine enterprise, which comprises an essential information and monitoring and maintenance submodule, a finance monitoring module, a goods buying-selling-stocking module, a production monitoring module and an industry monitoring module. The production monitoring system throughout the production and operating activities of an enterprise is developed according to the characteristics of the pharmaceutical industry, and the monitoring system comprises the following modules: the goods buying-selling-stocking module, the production monitoring module and the finance monitoring module, around all of which division of labor and coordination are carried out during planning programming and planning realization, and the industry characteristics are fully embodied, so that the production efficiency is improved, the quality of products is strictly controlled, and the requirements of the GMP in the pharmaceutical industry is met.

The present invention relates to corrosion inhibitor systems, in particular to cleaning and corrosion inhibiting compositions for surfaces of aluminum or colored metals and alloys thereof under alkaline conditions, especially in the food and pharmaceutical industries. The cleaning and corrosion inhibiting compositions comprise as a corrosion inhibitor at least one alkyleneoxy alkylphosphate di- or triester having the general formula (I) where Z is either —O—M or —O—(AO)n2— Alkyl wherein M is an ammonium, alkali metal or alkaline earth metal cation, Alkyl is a C5-C22 alkyl or alkylaryl group, AO is a C2-4-alkylene oxide unit and n1, n2 and n3 each are integers from 2 to 10.

A mixing system has a single-use container (1) with flexible walls and a mixing device. The mixing device has at least one encapsulated drive (5) and a mixer shaft (3). The drive (5) can be disposed of after use together with the mixer shaft (3) and the single-use container (1). The mixing system can be used in biotechnology and the pharmaceutical industry for mixing liquids, dissolving solids or cultivating cells and microorganisms.

The present invention relates to the field of producing starter cultures. In particular, a method for customers in need of a starter culture with a consistent quality, is provided. Specifically, the method involves the use of subsets of a stock inoculum material, which comprises a concentrate of starter culture organism cells to be propagated for direct inoculation of a cultivation medium, to obtain a starter culture whereby the conventional stepwise preparation of inoculum material for the production of a starter culture can be avoided. This novel method can be used for the manufacturing of starter cultures for the food, feed or pharmaceutical industry. Furthermore, the method is useful in the cultivation of cells expressing desired products, such as primary and secondary metabolites, including e.g. enzymes and flavors.

A business planning solution for sales force effectiveness in promoting products in a target market is provided. The planning solution analyzes sales and market data to identify target market segments that are likely to respond to sales force activity. Business resources can then be allocated to optimize sales force activity. Detailed sales call plans can be generated. The business planning solution may be implemented as a computer software application on conventional stand alone or networked computer arrangements. For pharmaceutical industry applications, the software application is configured to process pharmaceutical market research data.

The present invention relates to in situ compositions of mono- or diester dicarboxylates, methods employing these in situ compositions, and methods of making these in situ compositions. More particularly, the invention relates to mono- or diester dicarboxylate antimicrobial compositions that can reduce the population of microbes on various surfaces such as facilities, containers, or equipment found in food, beverage, or pharmaceutical processing, or in food, beverage, or pharmaceutical industries, at temperatures between about −70° C. to about 100° C.

A spectral imaging device with a narrow band spectrally tunable light source. The light source includes an optical parametric oscillator that can be tuned across a wide range of wavelengths while illuminating a target. In a preferred embodiment, a Q-switched YAG laser pumps the OPO. Two-dimensional images of the target may be detected at various wavelengths by a imaging sensor with a many pixel focal plane array to generate data arrays known as hyper-spectral image cubes. These images detecting variations is optical parameters including transmission, reflectivity, and fluorescence of the target can be obtained in various spectral ranges from ultraviolet to infrared for a variety of applications in metrology, agriculture, life sciences, and in the pharmaceutical industry.

The invention relates to novel forms of compounds displaying broad spectrum antibiotic activity, especially crystalline polymorphic forms and amorphous forms of such compounds, compositions comprising such crystalline polymorphic forms and amorphous forms of such compounds, processes for manufacture and use thereof. The compounds and compositions of the invention are useful in the pharmaceutical industry, for example, in the treatment or prevention of diseases or disorders associated with the use of antibiotics, chemotherapies, or antiviral therapies, including, but not limited to, colitis, for example, pseudo-membranous colitis; antibiotic associated diarrhea; and infections due to Clostridium difficile (“C. difficile”), Clostridium perfringens (“C. perfringens”), Staphylococcus species, for example, methicillin-resistant Staphylococcus, or Enterococcus including Vancomycin-resistant enterococci.

The present invention relates to a method for manufacturing glass containers for pharmaceutical use. This method allows obtaining containers with a low degree of alkalinity. In some preferred embodiments the process allows the manufacture of sterile containers and substantially free of particles ready to be used by the pharmaceutical industry.

The invention discloses a mirror finished stainless steel bearing and a process technology thereof, which comprise molding of an inner ring and an outer ring of a bar stock, turning operation, heat treatment, plane centerless grinding, coarsely grinding the channels of the inner and the outer rings, heat treatment, finely grinding the channels of the inner and the outer rings, heat treatment, grinding the channels of the inner and the outer rings, assembly and pressing fit a dust cap. The mirror finished stainless steel bearing and the process technology thereof are characterized in that: 9Cr18 stainless steel is adopted as the bar stock; liquid casting passivation is carried out before fine grinding of the channels of the inner and the outer rings; uniform burnishing treatment with a waxing machine is carried out to the inner ring surface, the two end surfaces and the two chamfers of the inner ring and the outer ring surface, the two end surfaces and the two chamfers of the outer ring after grinding the channels of the inner and the outer rings; the dust cap and a retainer adopt material of stainless steel 304, coated with a vacuum ion coating and colored into golden. The mirror finished stainless steel bearing of the invention has strong corrosion resistance and long service life and can be widely used in special environment, such as food machinery, chemical dyeing, marine equipment, pharmaceutical industry, assembly line of IT industry, etc.

The present invention relates to two solvent antimicrobial compositions and methods employing these two solvent compositions. The two solvent compositions typically contain a second solvent that is not or is only sparingly soluble in a diluting solvent. The two solvent composition can form a clear single-phase solution. The two solvent antimicrobial compositions can reduce the population of microbes on various surfaces such as facilities, containers, or equipment found in food, beverage, or pharmaceutical industries at temperatures between about −70° C. to about 100° C.

The invention is applicable within the food and pharmaceutical industry. More specifically, it relates to a novel strain of the species Bifidobacterium animalis subsp. lactis CECT 8145, the cell components, metabolites and secreted molecules thereof, which, incorporated into food and / or pharmaceutical formulations, can be used in the treatment and / or prevention of excess weight and obesity and related diseases such as metabolic syndrome, hypertension, glycemia, inflammation, type 2 diabetes, cardiovascular diseases, hypercholesterolemia, hormonal alterations, infertility, etc.

An electrolytic process of ozone generation using platinum-coated titanium grid as cathode, β-PbO2 deposited on the grid as anode, and batteries in conjunction with supercapacitors as a DC power source is described. No membrane is required to separate the electrodes, and a neutral salt such as NaCl is used to enhance the generation of ozone gas. The electrolytic apparatus comprising a cell, the electrodes, and a bubbler can also be inserted directly in water that needs ozone treatment. As batteries can power the ozone generation, the apparatus can be disposed at point-of-use and away from the city electricity. The electrolytic apparatus can be used for sterilization of water for pharmaceutical industry, household water supply, for surface cleaning of semiconductors, meats, fish, fruits, as well as for disinfection of SPA water and personal hygiene.

A novel class of gonane type and D-homo-gonane type steroids having sulfatase-inhibiting and / or estrogenic activity is presented for application in the pharmaceutical industry. The number and location of sulfamoyloxy groups on the steroids provides for sulfatase inhibiting and estrogenic activities that independently vary over a wide range, allowing the customization of the pharmaceutical for specific purposes, including treatment and diagnosis of estrogen-dependent tumors.

Disclosed is an impact-resistant modified polyamide moulding compound which is suitable in particular for the production of containers having a good oxygen barrier and low-temperature impact strength. Also disclosed are containers which are produced from the thermoplastic polyamide moulding compound. In particular, storage or transport containers for industrial chemicals, agrochemicals, the cosmetic industry, pharmaceutical industry or foodstuffs industry can be produced from the polyamide moulding compound of the invention.

The invention discloses a method for preparing total flavonoids of hovenia acerba. The method adopts one optional method of the solvent extraction method, the solvent extraction method, the macro-porous resin adsorption method, the liquid-liquid countercurrent distribution chromatography, the supercritical fluid extraction method or the column chromatography, or the free combination of the methods. The total flavonoids of hovenia acerba is prepared from any one part of hovenia acerba, such as fruit stems, fruits, seeds, seed-cases, roots, stems, leaves, flowers, branches, skins, skin and fruit residues, etc., and the combination thereof. The prepared total flavonoids is a combination of various flavonoid active components, wherein the total flavonoids comprises the main active components as follows: quercetin, kaempferol, (+)-dihydromyricetin, myricetin, north hovenia acerba alcohol, (+)-pyrocatechin, hovenia acerba I, hovenia acerba II, hovenia acerba III and the derivates thereof; the total percentage composition of various flavonoid components by the weight is 5% to 100%; and the preparation method is applicable to pharmaceutical industry, food industry, cosmetic industry and health-care product industry.

The invention discloses a method for preparing a red algae agar fiber. The method comprises the following steps of: cleaning fresh red algae, removing impurities and air-drying; crushing red algae and removing color; extracting agar polysaccharide with hot water, purifying and drying to obtain agar polysaccharide which is suitable for spinning; preparing an agar polysaccharide spinning solution with a certain concentration, performing wet spinning by using an ethanol aqueous solution or DMF (Dimethyl Formamide) aqueous water as a coagulating bath to obtain spinnable agar fiber; and washing, performing ethanol dehydration and air-drying to obtain a fiber material. The method has the advantage of fully utilizing living marine resources along with low-cost and readily available raw materials; and the obtained agar fiber is a pure natural alginate fiber, has high biocompatibility and biodegradability and can be used for clothing industry and pharmaceutical industry.

The invention relates to the technical field of wastewater treatment, and discloses a pharmaceutical wastewater treatment process which comprises steps: preforming wastewater pre-treatment and comprehensive treatment, pumping wastewater into a coagulation gas floatation clarifier, adding polyaluminum chloride and polyacrylamide in a water input pipeline through a coagulation medicine adding system, then enabling mixed wastewater to enter a three-phase catalytic oxidation tower, a coagulative precipitation tank, a pre-acidification pool, a thermoregulation pool, a UASB reaction pool and a combined type hydrolysis acidification pool sequentially, subjecting the mixed wastewater to hydrolysis acidification, enabling the wastewater to enter a primary A / O pool, a primary precipitation pool, a secondary A / O pool, a secondary precipitation pool, a Fenton oxidation pool and a tertiary precipitation pool sequentially, and discharging standard outlet water from a standard discharging opening. The process has the advantages of stable running effect, high ammonium-nitrogen removal rate, and low running cost, thereby being suitable for treatment of wastewater, which is refractory to degrade, in the pharmaceutical industry.

The present invention describes a new electrochemical biosensor comprising (i) a biocatalyst producing a pH change when interacting with the analyte to be determined and (ii) a compound exhibiting different redox properties both in its protonated and non-protonated forms (pH-sensitive redox compound). The elements described above are integrated in a biosensor system composed of a working electrode and a reference electrode connected to an ammeter. When the analyte is present, the system produces a current change that is proportional to the concentration of the analyte. The biosensors described herein can be used in the accurate detection of a wide range of analytes. They can be used in diagnostics, industrial processes, food and feed quality control, biotechnology, pharmaceutical industry, environmental monitoring and so on.

A utility hanger system for the food, beverage, and pharmaceutical industries has a main hanger member extending in an axial direction, which has an axially extending semicylindrical central segment of a first radius, the central segment terminating in first and second wings on opposite sides of the central segment. A slot extends axially along the main hanger member and is positioned between two rod holes. Rods extend through the rod holes to an overhead support member and are fixed to the main hanger member by nuts. Pipes and conduits are gripped within standoffs which space the pipes from the main hanger member with a hexagonal member which is bolted within the main hanger member slot. The pipes and conduits can be supported above or below the main hanger member.

The invention discloses a method for simultaneously producing pentosan and dietary fiber by a wheat bran enzyme engineering method, belonging to the food processing field of the deep processing transformation of the food processing by-product. The method takes industrial wheat outer bran as raw material; after the moisture and the Ph of the industrial wheat outer bran are regulated, cell wall lytic enzyme is adopted for being acted on the wheat bran; and then a screw extruder is adopted for extrusion expansion treatment; alkali liquor, the Ph of which is equal to 10, is used for extraction; and extraction solution obtained by decentralization is deproteinized, concentrated, and dried in vacuum to obtain pentosan. Precipitant obtained by alkali liquor extraction and decentralization is decolorized by H2O2 solution, washed, dried and ground to obtain dietary fiber. The technology can simultaneously produce pentosan and dietary fiber, also can only produce pentosan or dietary fiber according to market demands, and is flexible. The obtained pentosan and dietary fiber can serve as addition agent and functional factors, and are applied to food, pharmaceutical industries and cosmetic industries, thus realizing the effective transformation and utilization of the wheat bran.

The present invention belongs to the field of pharmaceutical industry and relates to a process for coating a particle comprising a pharmaceutically active ingredient (API) comprising the steps of providing a composition comprising carbonate ions, phosphate ions, or a mixture thereof, providing a particle comprising an API, and precipitating a carbonate salt, a phosphate salt or a mixture thereof onto said particles.The present invention is also directed to a particle comprising an API, wherein the particle is coated with a coating comprising a carbonate salt, phosphate salt, or mixture thereof, and to a pharmaceutical composition comprising said particles.Moreover, the present invention is also directed to the use of said particles for preparing a medicament,